U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.2547+5G>A AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 5, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003323578.2

Allele description [Variation Report for NM_000527.5(LDLR):c.2547+5G>A]

NM_000527.5(LDLR):c.2547+5G>A

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.2547+5G>A
HGVS:
  • NC_000019.10:g.11129675G>A
  • NG_009060.1:g.45295G>A
  • NM_000527.5:c.2547+5G>AMANE SELECT
  • NM_001195798.2:c.2547+5G>A
  • NM_001195799.2:c.2424+5G>A
  • NM_001195800.2:c.2043+5G>A
  • NM_001195803.2:c.2013+5G>A
  • LRG_274t1:c.2547+5G>A
  • LRG_274:g.45295G>A
  • NC_000019.9:g.11240351G>A
  • NM_000527.4:c.2547+5G>A
Links:
dbSNP: rs879255226
NCBI 1000 Genomes Browser:
rs879255226
Molecular consequence:
  • NM_000527.5:c.2547+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195798.2:c.2547+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195799.2:c.2424+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195800.2:c.2043+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195803.2:c.2013+5G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004028786Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jul 5, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations.

Setia N, Saxena R, Arora A, Verma IC.

Atherosclerosis. 2016 Dec;255:31-36. doi: 10.1016/j.atherosclerosis.2016.10.028. Epub 2016 Oct 14.

PubMed [citation]
PMID:
27816806

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004028786.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: LDLR c.2547+5G>A alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Four predict the variant weakens the canonical 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251266 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2547+5G>A has been reported in the literature in a three year old individual affected with familial hypercholesterolemia and her parents were reportedly consanguineous with elevated LDL cholesterol levels (example: Setia_2016). This report does not provide unequivocal conclusions about association of the variant with Familial Hypercholesterolemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 27816806). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as VUS (n=2) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024